tradingkey.logo

Novo Nordisk's CEO Says Still 'Incredibly Optimistic' About CagriSema

ReutersFeb 23, 2026 11:00 AM

- Novo Nordisk A/S NOVOb.CO:

  • NOVO NORDISK'S CHIEF SCIENTIFIC OFFICER: ASSUMING THAT THERE IS FURTHER WEIGHT LOSS POTENTIAL TO BE HAD WITH CAGRISEMA

  • NOVO NORDISK'S CEO: WE STRONGLY BELIEVE THAT CAGRISEMA HAS RIGHT NOW THE BEST WEIGHT EFFICACY THAN ANY PRODUCT CURRENTLY ON THE MARKET

  • NOVO NORDISK'S CEO: I AM STILL INCREDIBLY OPTIMISTIC ABOUT CAGRISEMA

  • NOVO NORDISK'S CEO: WE NEED TO BE AWARE THAT THERE IS AN ABNORMALITY WITH HOW THE COMPARATOR DRUG HAS PERFORMED IN THE STUDY

Further company coverage: [NOVOb.CO]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI